National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 60464-60465 [2021-23846]
Download as PDF
<![CDATA[
60464
Federal Register / Vol. 86, No. 209 / Tuesday, November 2, 2021 / Notices
experiences of persons at highest risk
for HIV infection.
The Centers for Disease Control and
Prevention requests a three-year
approval for a revised information
collection. Data will be collected
through anonymous, in-person
interviews conducted with persons
systematically selected from up to 14
cities throughout the United States;
these MSAs were chosen based on
having high HIV prevalence. A brief
screening interview will be used to
determine eligibility for participation in
the behavioral assessment. Participants
will be recruited through respondentdriven sampling, a scientifically proven
recruitment strategy for reaching
hidden, hard-to-reach, or stigmatized
populations. Interview data will be
recorded on secure portable computers,
without internet connections. Data will
be transferred to secure, encrypted data
servers. Data will be stored at CDC and
shared with local health departments in
accordance with existing data use
HIV, and (3) use of HIV prevention
services. All persons interviewed will
also be offered an HIV test and will
participate in a pre-test counseling
session. No other federal agency
systematically collects this type of
information from persons at risk for HIV
infection. These data have substantial
impact on prevention program
development and monitoring at the
local, state, and national levels.
The burden table below shows the
estimated annualized burden hours for
the participants’ time. Annually, 1,540
participants will complete an eligibility
screener (an average of 5 minutes to
complete), 1,400 participants will
complete the Behavioral Assessment (an
average of 40 minutes to complete), and
1,400 will complete the Recruiter
Debriefing Form (an average of two
minutes to complete). The total
estimated annualized burden is 1,110
hours. Participation of respondents is
voluntary. There are no costs to
respondents other than their time.
agreements and the Assurance of
Confidentiality for HIV/AIDS
Surveillance Data. Data will be
disseminated in aggregate through
academic and agency publications,
presentations, and reports. All required
data collection and activities will be
anonymous.
Personally identifiable information
(PII) is not included in the data
collection. The CDC Privacy Officer has
assessed this package for applicability of
5 U.S.C. 552a. The Privacy Act is not
applicable because PII is not being
collected under this CDC funded
activity. The NHBS-Trans formative
interview and optional HIV testing are
anonymous (neither names nor Social
Security numbers are collected). Data
that will be collected through NHBSTrans, while sensitive, are not
personally identifying. The data from
the behavioral assessment will provide
estimates of (1) behavior related to the
risk of HIV and other sexually
transmitted diseases, (2) prior testing for
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Persons Screened ............................
Eligible Participants ...........................
Peer Recruiters .................................
Eligibility Screener ............................
NHBS-Trans Interview .....................
Recruiter Debriefing .........................
1,540
1,400
1,400
1
1
1
5/60
40/60
2/60
129
934
47
Total ...........................................
...........................................................
........................
........................
........................
1,110
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–23872 Filed 11–1–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Charter Renewal for the National
Advisory Committee on Rural Health
and Human Services
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondents
ACTION:
Notice.
In accordance with the
Federal Advisory Committee Act of
1972, HHS is hereby giving notice that
the National Advisory Committee on
Rural Health and Human Services
(NACRHHS) has been renewed. The
SUMMARY:
VerDate Sep<11>2014
17:42 Nov 01, 2021
Jkt 256001
effective date of the charter renewal is
October 29, 2021.
FOR FURTHER INFORMATION CONTACT:
Sahira Rafiullah, Designated Federal
Officer, Federal Office of Rural Health
Policy, HRSA, 5600 Fishers Lane,
17W59D, Rockville, Maryland 20857;
301–443–7095; or SRafiullah@hrsa.gov.
SUPPLEMENTARY INFORMATION: The
NACRHHS provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning the activities
under Section 222 of the Public Health
Service Act, as amended, 42 U.S.C.
217a. Each year, the NACRHHS selects
one or more topics upon which to focus
during the year. By the end of the
calendar year, the Committee produces
a report or white papers with
recommendations on that issue for the
Secretary.
The NACRHHS charter renewal filing
date is October 29, 2021. Renewal of the
NACRHHS charter gives authorization
for the committee to operate until
October 29, 2023.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
A copy of the NACRHHS charter is
available on the NACRHHS website at
https://www.hrsa.gov/advisorycommittees/rural-health/. A copy of the
charter also can be obtained by
accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
website address for the FACA database
is https://www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–23829 Filed 11–1–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\02NON1.SGM
02NON1
Federal Register / Vol. 86, No. 209 / Tuesday, November 2, 2021 / Notices
jspears on DSK121TN23PROD with NOTICES1
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trial Readiness for
Rare Neurological and Neuromuscular
Diseases.
Date: November 18, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH NSC, 6001 Executive Blvd.,
Room 3208, MSC 9529, Bethesda, MD 20892,
(301) 496–9223, Ana.Olariu@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; HEAL Initiative: Planning
Studies for Initial Analgesic Development
Initial Translational Efforts [Small Molecules
and Biologics] (R61 Clinical Trial Not
Allowed).
Date: December 2, 2021.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Bo-Shiun Chen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892,
(301) 496–9223, bo-shiun.chen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 28, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–23846 Filed 11–1–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:42 Nov 01, 2021
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Chemistry, Biochemistry and
Biophysics.
Date: December 1–2, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ian Frederick Thorpe,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–8662, ian.thorpe@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–23795 Filed 11–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
60465
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Coordinating Center
for the NICHD Population Dynamics Centers
Research Infrastructure Program FY 2022
(R24 Clinical Trial Not Allowed).
Date: November 4, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892, (301) 451–4989,
crobbins@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research,
National Institutes of Health, HHS)
Dated: October 28, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–23849 Filed 11–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2021–0019; OMB No.
1660–0068]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; Federal
Hotel and Motel Fire Safety Declaration
Form
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: 30-Day notice of renewal and
request for comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA) will
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 86, Number 209 (Tuesday, November 2, 2021)]
[Notices]
[Pages 60464-60465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23846]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 60465]]
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Clinical Trial Readiness for Rare
Neurological and Neuromuscular Diseases.
Date: November 18, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Ana Olariu, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH NSC, 6001 Executive Blvd., Room 3208, MSC 9529, Bethesda, MD
20892, (301) 496-9223, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; HEAL Initiative: Planning Studies
for Initial Analgesic Development Initial Translational Efforts
[Small Molecules and Biologics] (R61 Clinical Trial Not Allowed).
Date: December 2, 2021.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Bo-Shiun Chen, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD
20892, (301) 496-9223, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: October 28, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-23846 Filed 11-1-21; 8:45 am]
BILLING CODE 4140-01-P
